The H3K4 methyltransferase Setd1b is essential for hematopoietic stem and progenitor cell homeostasis in mice

  1. Kerstin Schmidt
  2. Qinyu Zhang
  3. Alpaslan Tasdogan
  4. Andreas Petzold
  5. Andreas Dahl
  6. Borros M Arneth
  7. Robert Slany
  8. Hans Jörg Fehling
  9. Andrea Kranz  Is a corresponding author
  10. Adrian Francis Stewart  Is a corresponding author
  11. Konstantinos Anastassiadis  Is a corresponding author
  1. Technische Universität Dresden, Germany
  2. University Hospital Ulm, Germany
  3. Hospital of the Universities Giessen and Marburg, Germany
  4. Friedrich Alexander Universität Erlangen, Germany

Abstract

Hematopoietic stem cells require MLL1, which is one of six Set1/Trithorax-type histone 3 lysine 4 (H3K4) methyltransferases in mammals and clinically the most important leukemia gene. Here we add to emerging evidence that all six H3K4 methyltransferases play essential roles in the hematopoietic system by showing that conditional mutagenesis of Setd1b in adult mice provoked aberrant homeostasis of hematopoietic stem and progenitor cells (HSPCs). Using both ubiquitous and hematopoietic-specific deletion strategies the loss of Setd1b resulted in peripheral thrombo- and lymphocytopenia, multilineage dysplasia, myeloid-biased extramedullary hematopoiesis in the spleen, and lethality. By transplantation experiments and expression profiling we determined that Setd1b is autonomously required in the hematopoietic lineages where it regulates key lineage specification components, including Cebpa, Gata1, and Klf1. Altogether, these data imply that the Set1/Trithorax-type epigenetic machinery sustains different aspects of hematopoiesis and constitutes a second framework additional to the transcription factor hierarchy of hematopoietic homeostasis.

Data availability

Sequencing data have been deposited in GEO under accession code GSE97976

The following data sets were generated

Article and author information

Author details

  1. Kerstin Schmidt

    Stem Cell Engineering, Biotechnology Center, Technische Universität Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9596-4026
  2. Qinyu Zhang

    Genomics, Biotechnology Center, Technische Universität Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Alpaslan Tasdogan

    Institute of Immunology, University Hospital Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Andreas Petzold

    Deep Sequencing Group, DFG - Center for Regenerative Therapies Dresden, Technische Universität Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Andreas Dahl

    Deep Sequencing Group, DFG - Center for Regenerative Therapies Dresden, Technische Universität Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Borros M Arneth

    Institute of Laboratory Medicine and Pathobiochemistry, Molecular Diagnostics, Hospital of the Universities Giessen and Marburg, Giessen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Robert Slany

    Department of Genetics, Friedrich Alexander Universität Erlangen, Erlangen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Hans Jörg Fehling

    Institute of Immunology, University Hospital Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  9. Andrea Kranz

    Genomics, Biotechnology Center, Technische Universität Dresden, Dresden, Germany
    For correspondence
    andrea.kranz@biotec.tu-dresden.de
    Competing interests
    The authors declare that no competing interests exist.
  10. Adrian Francis Stewart

    Genomics, Biotechnology Center, Technische Universität Dresden, Dresden, Germany
    For correspondence
    francis.stewart@tu-dresden.de
    Competing interests
    The authors declare that no competing interests exist.
  11. Konstantinos Anastassiadis

    Stem Cell Engineering, Biotechnology Center, Technische Universität Dresden, Dresden, Germany
    For correspondence
    konstantinos.anastassiadis@tu-dresden.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9814-0559

Funding

Deutsche Forschungsgemeinschaft (SPP1463/2 KR2154/4-1)

  • Andrea Kranz

Else Kröner-Fresenius-Stiftung (Stipend to Alpaslan Tasdogan)

  • Alpaslan Tasdogan

Deutsche Forschungsgemeinschaft (SPP1463 SL27/7-2)

  • Robert Slany

Deutsche Forschungsgemeinschaft (SFB1074 project A2)

  • Hans Jörg Fehling

Deutsche Forschungsgemeinschaft (SPP1463/2 STE903/5-1)

  • Adrian Francis Stewart

Deutsche Forschungsgemeinschaft (SFB655 project B1)

  • Konstantinos Anastassiadis

Deutsche Forschungsgemeinschaft (SFB655)

  • Andreas Dahl

Dresden International PhD program

  • Kerstin Schmidt

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal experiments were performed according to German law and approved by the relevant authorities (Permit numbers: TVA 1188; AZ 55.2-2532-2-485; TVV 41/2016).

Copyright

© 2018, Schmidt et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,161
    views
  • 500
    downloads
  • 33
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Kerstin Schmidt
  2. Qinyu Zhang
  3. Alpaslan Tasdogan
  4. Andreas Petzold
  5. Andreas Dahl
  6. Borros M Arneth
  7. Robert Slany
  8. Hans Jörg Fehling
  9. Andrea Kranz
  10. Adrian Francis Stewart
  11. Konstantinos Anastassiadis
(2018)
The H3K4 methyltransferase Setd1b is essential for hematopoietic stem and progenitor cell homeostasis in mice
eLife 7:e27157.
https://doi.org/10.7554/eLife.27157

Share this article

https://doi.org/10.7554/eLife.27157

Further reading

    1. Genetics and Genomics
    2. Stem Cells and Regenerative Medicine
    Amy Tresenrider, Marcus Hooper ... Thomas A Reh
    Research Article

    Retinal degeneration in mammals causes permanent loss of vision, due to an inability to regenerate naturally. Some non-mammalian vertebrates show robust regeneration, via Muller glia (MG). We have recently made significant progress in stimulating adult mouse MG to regenerate functional neurons by transgenic expression of the proneural transcription factor Ascl1. While these results showed that MG can serve as an endogenous source of neuronal replacement, the efficacy of this process is limited. With the goal of improving this in mammals, we designed a small molecule screen using sci-Plex, a method to multiplex up to thousands of single-nucleus RNA-seq conditions into a single experiment. We used this technology to screen a library of 92 compounds, identified, and validated two that promote neurogenesis in vivo. Our results demonstrate that high-throughput single-cell molecular profiling can substantially improve the discovery process for molecules and pathways that can stimulate neural regeneration and further demonstrate the potential for this approach to restore vision in patients with retinal disease.

    1. Stem Cells and Regenerative Medicine
    Wei Zhou, Kezhang He ... Sheng Ding
    Research Article

    Adult mammals, unlike some lower organisms, lack the ability to regenerate damaged hearts through cardiomyocytes (CMs) dedifferentiation into cells with regenerative capacity. Developing conditions to induce such naturally unavailable cells with potential to proliferate and differentiate into CMs, that is, regenerative cardiac cells (RCCs), in mammals will provide new insights and tools for heart regeneration research. In this study, we demonstrate that a two-compound combination, CHIR99021 and A-485 (2C), effectively induces RCCs from human embryonic stem cell-derived TNNT2+ CMs in vitro, as evidenced by lineage tracing experiments. Functional analysis shows that these RCCs express a broad spectrum of cardiogenesis genes and have the potential to differentiate into functional CMs, endothelial cells, and smooth muscle cells. Importantly, similar results were observed in neonatal rat CMs both in vitro and in vivo. Remarkably, administering 2C in adult mouse hearts significantly enhances survival and improves heart function post-myocardial infarction. Mechanistically, CHIR99021 is crucial for the transcriptional and epigenetic activation of genes essential for RCC development, while A-485 primarily suppresses H3K27Ac and particularly H3K9Ac in CMs. Their synergistic effect enhances these modifications on RCC genes, facilitating the transition from CMs to RCCs. Therefore, our findings demonstrate the feasibility and reveal the mechanisms of pharmacological induction of RCCs from endogenous CMs, which could offer a promising regenerative strategy to repair injured hearts.